ISHAH FOWLER: Open Payments
NPI 1073081428 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $206 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $389 |
| Gilead Sciences, Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $77 |
| Janssen Biotech, Inc. | 3 | $66 |
| Intercept Pharmaceuticals, Inc. | 2 | $55 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
Products named: RINVOQ, OMVOH, TREMFYA, OCALIVA, CREON, REZDIFFRA, XIFAXAN, ENTYVIO.
Industry payments across ME — which companies pay providers there.
